Program 1 - Precision Screening
The Precision Screening program develops biomarker-based and multimodal screening approaches for earlier identification of health risk in populations where symptoms often appear late or are difficult to interpret.
Screening is most useful when it combines scientific accuracy with practical relevance. The Precision Screening program explores how biological signals, structured digital inputs and contextual risk information can work together to support earlier and more consistent decision-making.
Our work includes biomarker discovery, validation design, stratification logic and pathways for responsible communication of screening results. A central focus is how to develop methods that perform across diverse populations and care contexts, rather than only under narrow study conditions.
Current areas of work
The program currently investigates blood-based marker panels, low-burden risk questionnaires and combined models that use both laboratory and non-laboratory inputs. Several efforts are aimed at improving early referral quality in primary care and supporting more structured follow-up for people with unclear or low-grade symptoms.
Program Priorities
- Biomarker discovery and replication
- Cohort validation and recruitment design
- Risk communication and user understanding
- Equity analysis across age, geography and care access
- Feasibility of deployment in primary care pathwaysDownloadable files